Medical Microbiology articles for United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 434

Article ‘Count’ for Medical Microbiology.

Journal Count Share
3 2.17
Peptoid-Based Nanosheets Exhibiting Broad Antiviral Activity against Enveloped RNA Viruses 1.00
Unraveling the Antiviral Efficacy of Surfactants: Deactivation of Nonenveloped Viruses through Synergistic Electrostatic Mechanisms 1.00
Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on a Two-Dimensional Boron Nitride Platform 0.17
1 0.60
Tuning energy transport in helical protein nanotubes through side-chain modifications 0.60
1 0.83
Programmable DNA-Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes 0.83
3 2.30
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence 0.30
Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology 1.00
Estimating the undetected burden and the likelihood of strain persistence of drug-resistant iNeisseria gonorrhoeae/i 1.00
1 0.30
Adaptive admixture at ACKR1, the Duffy blood group locus, may have shaped Plasmodium vivax prevalence in Oman 0.30
1 1.00
A Phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis 1.00
2 1.64
Role of Casual Contact in Drug-Resistant Tuberculosis Transmission: A Molecular Epidemiology Study 0.64
Infant RSV infection disrupts β2 adrenergic airway relaxation via epithelial CXCL11 1.00
3 1.49
Synthetic O-Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non-Typhoidal Salmonella Serovars 1.00
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum 0.25
The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of iPlasmodium/i Phosphatidylinositol 4‐Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria 0.24
1 0.26
The Incubation Periods of Mpox Virus Clade Ib. 0.26
8 3.33
Scavenger receptor class F member 2 is an intracellular receptor for hepatitis B virus 0.13
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections 0.03
Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization 0.10
Dynamics of natural selection preceding human viral epidemics and pandemics 0.96
High-resolution in situ structures of hantavirus glycoprotein tetramers 1.00
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.08
Human monoclonal antibodies targeting A35 protect from death caused by mpox 0.98
Extensive cross-species transmission of pathogens and antibiotic resistance genes in mammals neglected by public health surveillance 0.05
5 1.57
Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential 0.84
Functional immune responses induced by a capsid assembly modulator in chronic hepatitis B virus-infected humanized mice 0.11
A conserved adaptor orchestrates co-secretion of synergistic type VI effectors in gut Bacteroidota 0.08
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes 0.11
pH-induced conformational changes and inhibition of the Lassa virus spike complex 0.43
2 2.00
Recent developments in antimicrobial polymers for biofilm inhibition 1.00
Development of covalent inhibitors for bacterial histidine kinases 1.00
1 1.00
Synthesis and immunological evaluation of the lipopolysaccharide outer core of iSalmonella/i for potential broad-spectrum protection against multiple iSalmonella/i serovars 1.00
34 27.37
Utility of Repeating Blood Cultures in Candidemia: Insights From 2 Large Clinical Data Repositories 0.81
Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance 0.07
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial 0.62
<atl>iCandida glabrata/i Emerges as the Most Common Cause of Candidemia: Analysis of a Large Hospital-Based Database, United States, 2016–2024</atl> 1.00
Trends in Reflexive HCV Testing in a National US Laboratory: A Retrospective Study from 2018-2024 1.00
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials 0.40
Immunomodulation in the Treatment of Disseminated Coccidioidomycosis 1.00
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years 0.10
Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity 1.00
Respiratory Syncytial Virus After CAR T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort 0.76
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020 1.00
Uncovering Household Tuberculosis Infection Testing and Care Patterns Using a Novel Bioinformatics Linkage Strategy 1.00
Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Condition 1.00
Personalized Antibiogram: A Novel Multi-Task Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile with Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae 1.00
Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory—November 2023–September 2024 1.00
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy 0.08
First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa 1.00
Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis 0.89
Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell–Depleting Therapy With COVID-19: A Target Trial Emulation Study 1.00
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season 1.00
Risk Factors Associated With Progression to Clinical Candida auris Infection Among Adults With Previous Colonization—Florida, 2019–2023 1.00
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity 0.82
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial 0.08
The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study 0.50
Clinical Outcomes of Mpox Disease in Patients Treated with Tecovirimat 1.00
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals 1.00
Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and Canada 0.90
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C 0.89
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial Virus 1.00
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study 0.54
Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus 1.00
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE) 1.00
Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized with RSV 1.00
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for RSV Disease Aged 18 to 59 Years 0.90
1 1.00
Assessing the potential impacts of California Senate Bill 27 (SB27) on the antimicrobial susceptibility of Escherichia coli from raw meat. 1.00
3 2.35
Hospital Environments Harbor Chlorhexidine-Tolerant Bacteria Potentially Linked to Chlorhexidine Persistence in the Environment 1.00
In Situ Quantification of Bacterial Surface Charge at the Single-Cell Level for Modeling Transport under Electric Fields 1.00
Dirt Floors and Domestic Animals Are Associated with Soilborne Exposure to Antimicrobial-Resistant E. coli in Rural Bangladeshi Households 0.35
2 0.54
The Unfinished Agenda in Helicobacter pylori Treatment: Resistance, Microbiome Effects, and Future Directions 0.50
Vonoprazan–tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial 0.04
5 1.72
Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis B 1.00
Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal 0.17
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study 0.21
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.05
Differential HCC risk among HBV indeterminate types at baseline and by phase transition 0.30
2 1.24
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies. 0.29
IL1β Signaling Mediates the Interaction Between Hepatitis B and C Viruses. 0.95
1 0.65
Quantifying within-household tuberculosis transmission: a systematic review and prospective cohort study 0.65
2 2.00
Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies 1.00
Durability of Respiratory Syncytial Virus Vaccine Effectiveness Among US Veterans 1.00
3 3.00
Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US 1.00
Economic Impact of Delaying the Infant Hepatitis B Vaccination Schedule 1.00
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children 1.00
1 1.00
Hepatitis C Screening in Emergency Departments 1.00
13 11.95
DNA-dependent RNA polymerase Incorporates β-D-N4-hydroxycytidine (NHC) Linking Molnupiravir to Host Transcription-Dependent Mutagenesis 1.00
Identification and characterization of inhibitors of the tuberculosis phosphatase PstP 1.00
Delineation of the Active Site of MtgB, a Cobalamin-dependent Glycine Betaine Methyltransferase 1.00
The RNA thermometer motif ROSE-G regulates ABC transporter gene expression in bacteria 1.00
Incorporation of arabinose-CTP and arabinose-UTP inhibits viral polymerases by inducing long pauses 0.75
A Variant of the MenB Strain of Synechocystis sp. PCC 6803 Disrupts a Stress Response Pathway Allowing DMPBQ to Occupy the A1 Sites of Photosystem I 0.89
Variation in type IV pilus stability modulates DNA uptake and biofilm formation 1.00
A Pseudomonas aeruginosa endolytic muramidase targets cell-wall peptidoglycan in bacterial competition 0.36
Variants of the Ebola virus matrix protein VP40 have differential effects on oligomerization and plasma membrane interactions 0.94
Subcellular determinants of orthoflavivirus protease activity 1.00
Crosstalk between iron and flavins in the opportunistic fungal pathogen Candida albicans 1.00
A kinetic model of copper homeostasis in Saccharomyces cerevisiae 1.00
Proton gradient controls the lateral rearrangement of inner membrane domains in response to membrane fluidizer stress in Mycobacterium smegmatis 1.00
2 2.00
Allocation of resources among multiple daughter cells 1.00
Mechanisms of nuclear segregation in a multinucleate multibudding yeast 1.00
5 4.36
HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort 1.00
Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models 1.00
Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells 0.81
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 0.55
Immune cells promote paralytic disease in mice infected with enterovirus D68 1.00
2 1.22
Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathology 1.00
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains 0.22
7 2.68
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares 0.17
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort 0.09
Single nucleotide polymorphisms in the bepirovirsen binding site have limited impact on treatment response in chronic hepatitis B 0.75
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection 0.50
A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C 0.58
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program 0.02
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.57
58 38.99
Investigation of correlates of protection against gonococcal infection by comparative immunoprofiling of responses in experimental and clinical studies 0.18
<atl>Vancomycin-resistant iEnterococcus/i often spreads from hospitalized patients into the local environment and less often spreads from the environment into patients</atl> 1.00
The Conundrum of Shiga Toxin-Producing Escherichia coli O157:H7 Persistence: Evidence for Locally Persistent Lineages 1.00
Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122 1.00
<atl>Safety and Immunogenicity of a Trivalent iSalmonella/i Conjugate Vaccine to iS./i Typhi, iS./i Typhimurium, and iS./i Enteritidis</atl> 0.75
Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection 1.00
Genetic Background Modulates Zoliflodacin and Gepotidacin Cross-Resistance and Fitness in Neisseria gonorrhoeae 1.00
Rotavirus-specific IgA and IgG Patterns During the First Two Years of Life in the PREVAIL Birth Cohort 1.00
Infant Infection With Respiratory Syncytial Virus Genotypes and Subsequent Childhood Asthma Risk 1.00
Bacterial Meningitis Epidemiology in Burkina Faso and Niger - High-Risk Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2023 0.34
Test Performance of Expired Malaria Rapid Diagnostic Tests: A pilot diagnostic accuracy study conducted in Western Uganda 0.43
Risk Factors for Immunological Sensitization to Mycobacterium tuberculosis and Progression to Incident TB Disease Among HIV-uninfected Adults in a High Burden Setting 0.12
Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study 0.02
Nasal Biomarkers of Acute Illness Severity and Predictors of Recurrent Wheeze in Respiratory Syncytial Virus (RSV) Infected Infants 1.00
<atl>Longitudinal Trends in Pediatric Non- iSalmonella/i Gram-negative Enterobacterales Infections at a Tertiary Care Center in West Africa, 2005-2023</atl> 0.33
Characterization of mouse-adapted Marburg and Ravn viruses in inbred BALB/c and outbred CD-1 mice 1.00
Accuracy of the Phenotypic 1G Test to Detect Mycobacterium tuberculosis and Drug Resistance From Sputa in the US-Mexico Border 0.71
Publicly Available Neisseria Gonorrhoeae Genomes Predominantly Represent In Vitro-Derived Nonpiliated Variants 1.00
High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India 0.25
False-positive malaria rapid diagnostic tests are prevalent among children under 5 years of age in Uganda 0.93
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus 0.81
<atl>CRISPR-Cas–associated SCC imec/i variants in methicillin-resistant iStaphylococcus aureus/i evade rapid diagnostic detection</atl> 1.00
Detection of Carbapenem-Resistant Bacteria in Skilled Nursing Facility Wastewater 1.00
How Pooled Procurement Can Expand Access to Novel Antibacterial Therapeutics Globally 1.00
Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic Fibrosis 1.00
Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens 0.14
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma 0.36
Immune responses to BK virus in renal transplant recipients receiving IVIG treatment 1.00
Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa 0.59
Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation 1.00
Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants 1.00
Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers 1.00
Spontaneous Clearance of Polymerase Chain Reaction–Positive Plasmodium vivax Parasitemia in Northwestern Thailand: An Epidemiological Perspective 0.10
Phylogenetic Context of Antibiotic Resistance Provides Insights into the Dynamics of Resistance Emergence and Spread 1.00
Essential Role of Clathrin and Lipid Rafts in pH-dependent Entry of Chandipura Virus: Independence From Caveolin Pathway 0.19
Population Structure of Escherichia coli Isolated From the Human Bloodstream, Human and Animal Feces, and the Environment in Northern Tanzania 0.40
Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection 1.00
Diagnostic Performance and Kinetics of Hepatitis E Viral RNA and IgM Antibody Test Positivity in a Genotype 1 Outbreak in South Sudan 0.11
Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023 0.45
The common cold is associated with protection from SARS-CoV-2 Infections 1.00
Genomic and phenotypic insights into antibiotic resistance and virulence of iKlebsiella pneumoniae/i from the environment in Southern Taiwan 0.14
iIn vivo/i evolution of iCandida auris/i multi-drug resistance in a patient receiving antifungal treatment 1.00
Human Metapneumovirus, Respiratory Syncytial Virus and Influenza Associated Pneumonia Hospitalizations in Colorado Adults Aged Over 50 Years: 2016-2023 0.67
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS) 0.87
Effectiveness of Long-Lasting Insecticide-Impregnated Bed Nets in Controlling iPhlebotomus argentipes/i in Sri Lanka: A Cluster Randomized Controlled Trial 0.38
A human monoclonal antibody targeting α-Gal ameliorates experimental cutaneous leishmaniasis 1.00
From Skin to Sequence: Pan-species Detection and Speciation of iLeishmania/i 1.00
Assessing the Potential of Sexual Transmission of Lassa Virus in a Natural Rodent Reservoir 0.20
Identification of Factors Contributing to Pathogenic Variability Among Lassa Virus Strains Using the Guinea Pig Model and Reverse Genetics 0.92
Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries 0.05
Serosurveillance Identifies an Endemic Hotspot of Lassa Fever in Faranah, Upper Guinea 0.08
Digital PCR Reveals High PvDBP1 but not PvEBP/DBP2 and PvRBP2b Copy Number in Plasmodium vivax From Duffy-Negative Individuals in Central Africa 0.50
Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice 1.00
Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018 1.00
GES-66: Characterization of a New β-Lactamase Gene Variant Detected in Klebsiella pneumoniae 0.28
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance 0.88
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death 0.77
Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance 0.04
2 2.00
Structural Basis for HIV-1 Maturation Inhibition by PF-46396 Determined by MAS NMR 1.00
Aspergillus fumigatus Metallothionein CmtA Binds and Receives a [2Fe-2S] Cluster from Monothiol Glutaredoxin GrxD 1.00
1 1.00
Antibiotic and Antiviral Prescribing for Long‐Term Care Residents With a scpCOVID/scp‐19 Diagnosis, March 2020–July 2023 1.00
1 1.00
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection 1.00
1 1.00
Nanoscale Temperature Increases Are Not Required for Molecular Stimulation Using Nanoparticles under Radiofrequency Magnetic Fields: A Thermal Energy Flux Mechanism of Remote Enzyme Stimulation 1.00
13 7.45
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk 0.06
Natural maternal immunity protects neonates from sepsis 0.73
Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor 1.00
Host control of persistent Epstein–Barr virus infection 0.00
Population-scale sequencing resolves determinants of persistent EBV DNA 0.55
Oral 4′-fluorouridine rescues nonhuman primates from advanced Lassa fever 1.00
Potent neutralization of Marburg virus by a vaccine-elicited antibody 0.65
Multiple LDLR family members act as entry receptors for yellow fever virus 1.00
Heat-rechargeable computation in DNA logic circuits and neural networks 1.00
SuFEx-based antitubercular compound irreversibly inhibits Pks13 0.96
Non-antibiotics disrupt colonization resistance against enteropathogens 0.12
Targeting de novo purine biosynthesis for tuberculosis treatment 0.27
R9AP is a common receptor for EBV infection in epithelial cells and B cells 0.11
1 0.50
Machine learning enables scalable and systematic hierarchical virus taxonomy 0.50
1 1.00
P4-ATPases control phosphoinositide membrane asymmetry and neomycin resistance 1.00
119 75.28
Secretin-interacting plug proteins prevent antibiotic influx during type IV pilus assembly in Pseudomonas aeruginosa 0.25
Structure of ergosteryl-aspartate synthase reveals how an entrapped tRNA is used like a prosthetic swinging arm in the synthesis of aminoacylated sterols 0.20
Long-term spatiotemporal evolution of drug-resistant Mycobacterium tuberculosis in China 0.15
SARS-CoV-2 infection and vaccination elicit distinct pharyngeal mucosal B cell responses in children 1.00
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors 1.00
OC43 clinical isolate spike proteins have distinct carbohydrate-binding properties 0.13
Asymmetric structural transitions in the icosahedral organization of Eastern equine encephalitis virus 1.00
Modular small RNA drives the emergence of virulence traits and environmental trade-offs in Vibrio cholerae 1.00
Extensive cryptic circulation sustains mpox among men who have sex with men 1.00
Conserved pathogenesis of ancestral and contemporary Oropouche virus strains in a murine pregnancy model 0.79
Maternal RSV vaccination generates high-affinity antibodies that efficiently transfer to infants, providing enhanced passive immunity 1.00
Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution 0.75
Cellular and molecular basis of Coronin function in artemisinin resistance in 1.00
Orchestrated and dynamic nucleotide addition cycle during respiratory syncytial virus early-stage elongation 1.00
PE/PPE proteins contribute to Mycobacterium tuberculosis drug resistance 1.00
Nasopharyngeal carcinoma screening using Epstein–Barr virus Cp methylation triage in two population-based screening cohorts 0.09
Wastewater intelligence predicts the emergence of clinically-relevant and drug-resistant Candidozyma auris at healthcare facilities 1.00
Viral introductions and return to baseline sexual behaviors maintain low-level mpox incidence in Los Angeles 1.00
Potent acridone antimalarial against all three life stages of Plasmodium 0.88
The Mycobacterium abscessus cytochrome bcc:aa3 oxidase structure paves the way for an agent targeting subunit QcrB 0.14
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance 0.81
Major human schistosome species express different glycans with immunological and diagnostic implications 0.14
Activation of l-histidine biosynthesis as a new antibiotic strategy against Mycobacterium tuberculosis 0.27
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.12
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum 1.00
Development of a potent monoclonal antibody for treatment of human metapneumovirus infections 1.00
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design 0.83
Rational design and in vivo validation of capsid inhibitors for enterovirus D68 1.00
Degraders of the dengue virus capsid protein exhibit differentiated pharmacology relative to capsid inhibitors 1.00
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses 0.96
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants 0.08
PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of species into erythrocytes 0.11
Pangenome dynamics and population structure of the zoonotic pathogen Salmonella enterica serotype Hadar 0.85
Collagen binding adhesin restricts Staphylococcus aureus skin infection 0.89
A common DNA deletion altering the 3’UTR of is associated with reduced mefloquine susceptibility in parasites from Cambodian patients 0.40
Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults 0.05
Cryo-electron tomography reveals coupled flavivirus replication, budding and maturation 0.11
A single valine to leucine switch disrupts Plasmodium falciparum AP2-G DNA binding and reveals GDV1’s role in ap2-g activation 1.00
Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals 1.00
Predicting age of respiratory syncytial virus infection from birth timing 1.00
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine development 0.98
Neutralizing human monoclonal antibodies to poliovirus map to the receptor binding site 1.00
Structural basis for childhood antibody recognition of the human metapneumovirus fusion protein 0.69
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study 0.12
β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection 1.00
Interplay between climate and childhood mixing can explain a sudden shift in RSV seasonality in Japan 0.96
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modification 0.79
Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin 0.14
The rise and global spread of IMP carbapenemases (1996-2023): a genomic epidemiology study 0.17
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection 0.08
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.02
CD44 cross-linking promotes Plasmodium falciparum invasion 0.75
Molecular basis for multidrug efflux by an anaerobic-associated RND transporter 0.13
Genomic surveillance uncovers regional variation in HCV transmission networks in rural United States 0.96
SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness 1.00
Development of ACE2-tropic-betacoronavirus therapeutics for future pandemic preparedness 1.00
An essential adaptor for apicoplast fission and inheritance in malaria parasites 1.00
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution 0.10
Staphylococcus aureus induces Gasdermin A-dependent keratinocyte pyroptosis 0.71
Contribution of maternal gut carriage to neonatal acquisition of extended-spectrum beta-lactamase-producing Enterobacterales in Madagascar and Cambodia 0.03
High-resolution proteomics unveils salivary gland disruption and saliva-hemolymph protein exchange in Plasmodium-infected mosquitoes 0.87
Control of Mycobacterium tuberculosis protein secretion by ESX-4 and the outer membrane EsxUT-EsxEF complex 1.00
Inferring asymptomatic carriers of antimicrobial-resistant organisms in hospitals using genomic, microbiological and patient mobility data 1.00
Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2 0.02
Prognostic value of an abnormal chest X-ray result in predicting the development of tuberculosis 0.13
Structure of the human astrovirus capsid spike in complex with the neonatal Fc receptor 0.83
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens 0.18
Structural basis for 3C and 3CD recruitment by enteroviral genomes during negative-strand RNA synthesis 1.00
Endogenous structure of antimalarial target ATP4 reveals an apicomplexan-specific P-type ATPase modulator 1.00
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents 1.00
Structural basis of measles virus polymerase inhibition by nonnucleoside inhibitor ERDRP-0519 1.00
Patterns of genomic deletions in monkeypox virus during the 2022 outbreak in the United States 1.00
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study 1.00
A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4 1.00
Secretins of type-two secretion systems are necessary for exopolymeric slime secretion in cyanobacteria and myxobacteria 0.33
Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivo 1.00
Genomic epidemiology of mpox virus during the 2022 outbreak in New York City 1.00
Unraveling the role of viral interference in disrupting biennial RSV epidemics in northern Stockholm 0.60
Epigenetically conferred ring-stage survival in against artemisinin treatment 0.17
Basis for selective drug evasion of an aminoglycoside-resistance ribosomal RNA modification 1.00
motility is associated with inter-animal transmission 1.00
Structural elucidation of a unique binding mode by an intact alphavirus human IgG molecule to a quaternary epitope 1.00
Cross-membrane cooperation among bacteria can facilitate intracellular pathogenesis 1.00
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019–2024 0.38
Worldwide genetic diversity of vivax is consistent with natural selection by anopheline mosquitoes 0.75
Using COVID-19 pandemic perturbation to model RSV-hMPV interactions and potential implications under RSV interventions 0.70
Microhaplotype deep sequencing assays to capture infection lineages 0.05
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma 0.04
Acquisition of carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger 0.03
The structure of the Tad pilus alignment complex reveals a periplasmic conduit for pilus extension 0.11
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study 0.11
Genes linked to schistosome resistance identified in a genome-wide association study of African snail vectors 0.43
Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics 0.05
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors 0.99
De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen 0.94
Diversity and transmission and zoonotic potential of microbes in true insectivores 0.09
Synchronized seasonal excretion of multiple coronaviruses coincides with high rates of coinfection in immature bats 0.61
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys 0.95
Trehalose catalytic shift inherently enhances phenotypic heterogeneity and multidrug resistance in Mycobacterium tuberculosis 0.69
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2 0.65
Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR 0.73
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2 1.00
Context-Seq: CRISPR-Cas9 targeted nanopore sequencing for transmission dynamics of antimicrobial resistance 0.78
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.09
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids 0.03
Arginine regulates the mucoid phenotype of hypervirulent Klebsiella pneumoniae 1.00
Effective treatment of systemic candidiasis by synergistic targeting of cell wall synthesis 0.13
CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa 0.06
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease 0.74
Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline 1.00
A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis 0.80
Variation and prognostic potential of the gut antibiotic resistome in the FINRISK 2002 cohort 0.08
Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China 0.02
Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins 1.00
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses 1.00
Cryo-EM structures of the Ton and Tol motor complexes 0.71
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens 0.83
Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome 0.05
Bioenergetic stress potentiates antimicrobial resistance and persistence 0.92
1 0.88
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans 0.88
10 2.63
Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone 0.27
Evidence of monkeypox virus clade IIb lineage A.2.2 in the Republic of the Congo and co-circulation of clade Ia, Ib and clade IIb 0.06
Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals 0.03
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.09
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis 1.00
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial 0.09
A combination typhoid and non-typhoidal polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial 0.78
Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020 0.02
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial 0.25
Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns 0.03
2 1.70
TMPRSS2-mediated coronavirus spike activation and inhibition 0.83
Integrated structural biology of the native malarial translation machinery and its inhibition by an antimalarial drug 0.88
9 7.45
Environmental redox conditions and strain variation define phenazine-mediated antagonism in co-infecting bacteria 0.87
Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infection 1.00
Systematic identification of Salmonella T6SS effectors uncovers diverse new families and lipid-targeting activities 0.42
Magnesium depletion by Candida albicans unleashes two unusual modes of colistin resistance in Pseudomonas aeruginosa with different fitness costs 0.95
Recurrent mutations in the stress regulator Cap1 reveal a trade-off between azole resistance and oxidative stress response in Candida albicans 1.00
Characterization of RNA interference in the cnidarian Nematostella vectensis reveals partial target silencing but lack of small RNA amplification 0.43
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing 1.00
Egress-enhancing mutation reveals the inefficiency of non-enveloped virus cell exit 1.00
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. 0.78
4 2.83
Loss of DNA mismatch repair genes leads to acquisition of antibiotic resistance independent of secondary mutations 1.00
Twitching motility suppressors reveal a role for FimX in type IV pilus extension dynamics. 0.33
Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli. 1.00
Polymerization and flanking domains of the bactofilin BacA collectively regulate stalk formation in Asticcacaulis biprosthecum 0.50
4 0.94
Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study 0.03
Exposure to antibiotics during pregnancy or early infancy and the risk of autoimmune disease in children: A nationwide cohort study in Korea 0.07
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials 0.68
Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019 0.15
35 25.45
Epstein–Barr virus (EBV) infection causes human germinal center B cell–derived lymphomas in the absence of EBNA2 expression 1.00
Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor 0.73
Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block 1.00
Extensive heterozygosity and genetic exchange among natural populations of Leishmania species 0.38
Constrained evolutionary funnels shape viral immune escape 0.50
SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress response 1.00
Germline-targeted baboon apolipoprotein L-1 protects mice against African trypanosomes 1.00
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.31
Genomic epidemiology of Salmonella and Campylobacter in poultry production: Quantifying the contribution of primary breeders 1.00
EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis 0.31
Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2 1.00
Antagonism of RNA silencing in the yellow fever mosquito, Aedes aegypti, by the nsP2 protein of the prototype alphavirus 1.00
Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication 1.00
Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis 0.12
Structural characterization of the HDV virion and its ribonucleoprotein 1.00
Redefining Shiga toxin–induced human cell death as NLRP1- and gasdermin E-mediated pyroptosis 1.00
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.47
Antibody responses to a highly conserved peptide in HCV E2 protein correlate with chronicity or spontaneous clearance of HCV infection 1.00
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence 0.64
Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia 1.00
Anellovirus protein encoded by ORF2/3 functions as the viral replication initiation protein 1.00
Antibiotics accumulate in Klebsiella pneumoniae liver abscesses but fail to eliminate antibiotic-tolerant populations 1.00
Chemical propulsion of hemozoin crystal motion in malaria parasites 1.00
A nonenzymatic effector disrupts Bacteroides cell wall homeostasis via OmpA targeting to mediate interbacterial competition 0.07
Structural insights into the dynamic mechanism of bornavirus polymerase 1.00
SARS-CoV-2-derived RNA replicons as safe and effective vaccines 0.04
SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait 0.07
Quantifying phage infectivity from characteristics of bacterial population dynamics 0.80
Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape 0.75
Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion 1.00
Metabolic rewiring of isoniazid sensitivity in Mycobacterium tuberculosis 0.90
A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni 1.00
Tat-dependent bundling pilus of a halophilic archaeon assembles by a strand donation mechanism and facilitates biofilm formation 0.25
A multifunctional anti-O-Antigen human monoclonal antibody protects against Shigella sonnei infection in vivo 0.12
Competition for Hfq drives kinetic selection of mRNA targets by Escherichia coli small noncoding RNAs 1.00
4 2.95
Bacteria deliver a microtubule-binding protein into mammalian cells to promote colonization 0.76
Modulation of methyl–coenzyme M reductase expression alters the isotopic composition of microbial methane 1.00
Pre-European contact leprosy in the Americas and its current persistence 0.25
Pan-viral ORFs discovery using massively parallel ribosome profiling 0.94
15 11.58
Enterovirus-induced cleavage of Mitofusin 2 generates mitophagosomes for enveloped virion release 1.00
A periplasmic protein complex mediates arabinofuranosyltransferase activity and intrinsic drug resistance in Mycobacterium tuberculosis 1.00
Structural insights into the mechanism underpinning iron piracy in pathogenic Neisseri 1.00
<atl>A conserved glycan motif induces broadly reactive functional antibodies against the zoonotic pathogen iStreptococcus suis/i</atl> 0.27
DksA inhibitors against intracellular and persistent Salmonella are effective in acute models of infection 1.00
RTX-family toxin EhxA drives morphological remodeling and thrombogenesis in RBCs during enterohemorrhagic Escherichia coli infection 0.17
Efflux pumps control intracellular drug-target kinetics by limiting rebinding in bacteria 1.00
Structures of Vibrio cholerae transcription complexes reveal how ToxR and TcpP recruit the RNA polymerase and activate virulence genes 0.29
The Yeh pilus adhesin is equipped with an α-helical flap motif, which contributes to pectin adherence 0.94
Urban contact patterns shape respiratory syncytial virus epidemics with implications for vaccination 0.83
1′-Cyanocytidine-5′-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters 0.85
Ultrastrong Staphylococcus aureus adhesion to human skin: Calcium as a key regulator of noncovalent interactions 0.27
Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families 0.96
Fitness seascapes are necessary for realistic modeling of the evolutionary response to drug therapy 1.00
Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 protease 1.00
12 8.66
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+ T cell responses 1.00
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs 1.00
Design of a neutralizing and protective pan–encephalitic alphavirus receptor decoy protein 1.00
A systems immunology approach reveals divergent immune profiles of RSV and SARS-CoV-2 infections in infants 1.00
Inhaled nitric oxide at 300 ppm treats multidrug-resistant Pseudomonas pneumonia in swine and is safe in humans 1.00
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.38
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes 0.83
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153 0.15
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum 0.20
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques 1.00
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies 1.00
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo 0.10
4 2.44
Structure and function of a fungal AB toxin-like chimerolectin involved in anti-nematode defense 0.05
Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria 0.50
The Plasmodium CSP repeats have elastic properties with a critical role in sporozoite motility 0.89
Host cell and viral protease targets of human SERPINs identified by in silico docking. 1.00
1 0.30
“Paraxenoviridae”, a putative family of globally distributed marine bacteriophages with double-stranded RNA genomes 0.30
1 0.06
Human retinoic acid–inducible gene I (RIG-I) deficiency associated with susceptibility to classic Kaposi sarcoma 0.06
5 1.38
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme 0.04
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial 0.61
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial 0.37
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi 0.25
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study 0.12
6 1.35
7-year trend of timely hepatitis B birth dose vaccination coverage in The Gambia: a retrospective, population-based analysis 0.02
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study 0.18
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study 0.26
Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study 0.59
Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial 0.16
The impact and cost-effectiveness of pulse oximetry and oxygen on acute lower respiratory infection outcomes in children in Malawi: a modelling study 0.15
8 2.67
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.13
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts 0.38
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients 0.12
Tecovirimat for the Treatment of Mpox 0.96
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D 0.53
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 0.04
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.50
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.02
1 0.08
Sec62 restricts ER-replicating positive-strand RNA virus infections via UPR-dependent ER-phagy 0.08

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.